Livongo Revenue and Competitors

Location

$235M

Total Funding

Estimated Revenue & Valuation

  • Livongo's estimated annual revenue is currently $18.8M per year.(i)
  • Livongo received $105.0M in venture funding in April 2018.
  • Livongo's estimated revenue per employee is $140,000
  • Livongo's total funding is $235M.

Employee Data

  • Livongo has 134 Employees.(i)
  • Livongo grew their employee count by -15% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$148.5M7424%$256.5M$1B
#2
$31.6M210-5%$195.7MN/A
#3
$8.7M6740%N/AN/A
#4
$40.3M26811%$101MN/A
#5
$282.1M1409-22%$657.3M$3.7B
#6
$82.7M465-1%$373M$2B
#7
$28.9M25210%$169MN/A
#8
$15.3M109-42%$106.2MN/A
#9
$781.7M20684%N/AN/A
#10
$47.3M21511%N/AN/A
#11
$1.4M210%$4.7MN/A
#12
$0.9M11N/AN/AN/A
#13
$87.1M4731%N/AN/A
#14
$32.3M210N/AN/AN/A
#15
$11.9M8527%N/AN/A
#16
$6.8M52N/AN/AN/A
#17
$13.1M905%N/AN/A
#18
$142.9M704N/AN/AN/A
#19
$0.7M9N/AN/AN/A
#20
$15.1M62N/AN/AN/A
Add Company

Livongo empowers people with chronic conditions to live better and healthier lives. We make it easier for people to stay healthy, starting with our diabetes prevention, and diabetes and hypertension offerings, by driving behavior change through the combination of consumer health technology, personalized recommendations, and real-time support at the point of impact. Powered by advanced data science, we create personalized experiences for our members, so they receive the right information, tools, and support, at the right time. Our approach is leading to better financial and clinical outcomes while creating a better experience for people with chronic conditions and their care team of family, friends, and medical professionals.

keywords:Fitness and Wellness,Healthcare,Medical Diagnostics,Pharmaceuticals

$235M

Total Funding

134

Number of Employees

$18.8M

Revenue (est)

-15%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Livongo's People

NameTitleEmail/Phone
1
Workplace CoordinatorReveal Email/Phone
2
Growth Marketing Manager, MedicareReveal Email/Phone
3
Director Product MarketingReveal Email/Phone
4
Staff Product ManagerReveal Email/Phone
5
ParalegalReveal Email/Phone
6
EmployeeReveal Email/Phone
7
Project ManagerReveal Email/Phone
8
Director, Client SuccessReveal Email/Phone
9
Manager, Email Marketing AutomationReveal Email/Phone
10
Sr. Account ExecutiveReveal Email/Phone

Livongo News

2022-04-20 - Teladoc takes a hit with $6.6 billion impairment charge on ...

Teladoc had warned investors in February that the Livongo acquisition — part of Teladoc's vision for a unified digital health platform — could...

2022-04-20 - Teledoc records $6.6B impairment charge amid tough ...

Teladoc closed its $18.5 billion purchase of Livongo in November 2020 in a merger that held the promise of creating a telehealth behemoth.

2022-04-20 - Teladoc reports $6.6B impairment charge for Livongo ...

Teladoc completed its $18.5 billion acquisition of Livongo in October 2020, however, the merger has struggled, resulting in the large...

2021-10-28 - Livongo Exec Launches FemTec Health with $38M to Transform Healthcare Experience for Women

FemTec Health’s Services What You Should Know: – Today, former Livongo executive Dr. Kimon Angelides announced the launch of FemTec Health, a women’s health sciences and beauty company with $38M in funding focused on using technology and data to transform the total healthcare experience for wo ...

2021-05-18 - Click-and-mortar is a better model for healthcare

Richard Lu Contributor Share on Twitter Richard Lu, MBA, is a medical student at Harvard Medical School. Jennifer Schneider Contributor Share on Twitter Jennifer Schneider, M.D., is an entrepreneur-in-residence at General Catalyst and the former president of Livongo. Bob Kocher Contributor ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$19.4M134N/AN/A
#2
$19.4M134N/AN/A
#3
$40.2M134N/AN/A
#4
$19.6M135-7%N/A
#5
$17.8M137-7%$171.5M

Livongo Funding

DateAmountRoundLead InvestorsReference
2014-09-11$10.0MAGeneral Catalyst PartnersArticle
2015-04-08$20.0MBKPCBArticle
2016-04-13$44.5MCMultipleArticle
2016-04-26$49.5MCMultipleArticle
2017-03-17$52.5MUndisclosedMultipleArticle
2018-04-12$105.0MUndisclosedGeneral CatalystArticle